Testing a new drug's safety in healthy volunteers
Part of Brain & nervous system clinical trials.
This trial tests a new investigational drug called LY03017 to see if it's safe and how the body processes it. It is for healthy volunteers between 18 and 45 years old.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy man or woman aged 18 to 45.
- Men must weigh at least 110 lbs (50 kg), women at least 99 lbs (45 kg), and your body mass index (BMI) must be between 18.5 and under 28.
- You must be willing to follow lifestyle rules, including avoiding certain foods and drinks like grapefruit, coffee, and chocolate before and during the trial.
- You cannot have a history of serious medical conditions, allergies to the drug or similar drugs, or abnormal heart, blood pressure, or lab test results.
- You must not smoke more than 5 cigarettes a day, abuse alcohol or drugs, or have used prescription or over-the-counter medications recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how a new investigational drug (LY03017) moves through the body in younger adults and older adults, and whether food changes that. It will help researchers understand how to dose the medicine.
This trial tests a new medicine called LY03021 in healthy volunteers to see how safe it is, how the body processes it, and if food changes its effects. It's for people who are generally healthy and not taking other medications.
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
This study tests the safety of a new medication called LY03020. It is for healthy volunteers and for people with stable schizophrenia. The study aims to see how well the body handles the drug and what side effects might occur.
This trial tests if LY03020 helps people with schizophrenia who are currently having a severe episode. If you have acute symptoms like hallucinations or delusions, this study could be an option.
This trial tests a new medicine called LY4006895 in two groups: healthy volunteers and people with early symptomatic Alzheimer's disease. It aims to see how the drug works in the body and if it might help memory and thinking.
Hear when a new Hallucinations and Delusions Associated With Alzheimer's Disease Psychosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.